Project Grant R61AG092355
- This $4,924,374 Project Grant award, with an initial term from September 1, 2025 to July 31, 2029, is provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award aims to validate novel biomarkers that capture the most relevant features of cognitive fluctuations in Alzheimer's disease (AD) and dementia with Lewy bodies (DLB). The project will provide a multimodal characterization of the frequency and severity of cognitive...
- The National Institute on Aging (NIA) awarded a $416,238 Project Grant under CFDA 93.866 Aging Research to Wisconsin Evangelical Lutheran Synod Kingdom Workers, Inc. for the "Project GLORY: Good Life in Memory Care" program. This project aims to contribute to understanding how to ensure a "good life" for nursing home residents with Alzheimer's disease and related dementias (ADRD). The key objectives are to: 1) obtain first-hand experiences from ADRD residents, their families,...
- The National Institute on Aging (NIA), part of the Department of Health and Human Services National Institutes of Health, awarded a $3.37 million Project Grant to The University of Texas at Arlington to develop an individualized deep connectome framework for Alzheimer's disease and related dementias (ADRD) analysis. The three-year grant, awarded on August 18, 2022 under the NIA's Aging Research program (CFDA 93.866), will support research to discover and identify individualized...
- This federal Cooperative Agreement award for $455,035 was granted on August 15, 2025 by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866). The award, titled "Leading Equitable Research in Alzheimer's Disease in Africa (LEAD Africa)," aims to establish an Alzheimer's disease and related dementias (AD/ADRD) research infrastructure in resource-limited areas of Africa. The project will be executed through a collaboration between research...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $344,164 project grant to Northwestern University to develop "M4: Modules on Advanced Methodology When Modeling Multinational Data." The primary objectives are to: 1) create a training program in large-scale data analysis for the next generation of researchers, 2) instruct trainees on protective behavioral and social factors related to Alzheimer's disease and related dementias...
- The National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), awarded a $770,558 project grant to Wake Forest University Health Sciences (WFUHS) to establish connections between Alzheimer's disease (AD)-related genomic markers and neuroimaging phenotypes. The objective is to determine the heterogeneity of AD subtypes and their association with the clinical onset of dementia. The project aims to develop data-driven computational models using multi-modal...
- This federal Project Grant award of $2,631,670 from the National Institute on Aging (CFDA 93.866 Aging Research) supports a research initiative at The Washington University to investigate age-related deficits in episodic memory. The project aims to determine how aging distinctly affects the content and structure of memory representations, and how this relates to dysfunction in different brain networks based on susceptibility to Alzheimer's disease pathology. The research will utilize plasma...
- This Project Grant award for $301,417 was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to the University of Arizona. The award aims to develop innovative methods and tools for integrating data from Alzheimer's disease and related dementias (AD/ADRD) studies to address challenges posed by inconsistencies among evidence from different studies, particularly for comparative effectiveness research. The project has two main...
- The National Institute on Aging (NIA) awarded a $773,816 project grant under the Aging Research federal grant program (CFDA 93.866) to the University of California, Irvine (UCI) to conduct comparative studies on new tau-directed Alzheimer's disease (AD) and AD-related dementias (ADRD) mouse models and human AD/ADRD brain tissues. The project aims to generate single-cell spatial proteo-transcriptomics maps to molecularly characterize aberrant RNA splicing and abnormal protein products in specific...
- The National Institute on Aging (NIA) has awarded a $640,906 project grant under CFDA 93.866 Aging Research to the University of Wisconsin-Madison to conduct research on "Elucidating Cerebrovascular Disease Pathways to Cognitive Decline with Vascular Neuroimaging." The 5-year project aims to utilize advanced neuroimaging techniques to understand the vascular contributions to cognitive impairment and dementia (VCID), and assess their relationship to Alzheimer's disease proteinopathy....
The National Institute on Aging (NIA), through the Aging Research Federal Grant Program (CFDA 93.866), awarded a $758,049 Project Grant to the University of Wisconsin-Madison to establish the Lucidity in Alzheimer's and Dementia (LEAD) Network. This interdisciplinary research infrastructure will facilitate collaborations and advance measurement science on lucid episodes (LE) - transient recoveries of function observed in some individuals with advanced Alzheimer's disease and related dementias. The LEAD Network aims to identify research priorities and strategies to improve measurement of LE and their impact on care delivery and caregiving (R61 phase), and then establish an operational infrastructure to support the development, testing, refinement, and dissemination of related research. This 2-year, $758,049 award will run from September 2025 through August 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $758.0k | 9/8/25 |